Multilink stent promotes less platelet and leukocyte adhesion than a traditional stainless steel stent: An in vitro experimental study

Journal of Investigative Medicine

Volumn 49, Issue 3, 2001, Pages 265-272

  Amoroso, Giovanni ^a   Van Boven, Ad J ^a   Volkers, Corine ^a   Crijns, Harry J G M ^a   Van Oeveren, Wim ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Adhesion; Antiaggregant; Hemo compatibility; Leukocytes; Platelets; Stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; INDOMETACIN; CD11B ANTIGEN;

ARTICLE; ASSAY; BIOCOMPATIBILITY; BLOOD CELL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LEUKOCYTE ADHERENCE; NORMAL HUMAN; SCANNING ELECTRON MICROSCOPY; STENT; THROMBOCYTE ADHESION; COMPARATIVE STUDY; CORONARY STENT; CORONARY STENTING; EXPERIMENTAL STUDY; INTERMETHOD COMPARISON; STAINLESS STEEL STENT;

EID: 0035005536     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. The BENESTENT study. N Engl J Med 1994;331:489-495.
2. Peterson ED, Lansky AJ, Anstrom KJ, Muhlbaier LH, Popma JJ, Satler LF, Lanzilotta MJ. Evolving trends in interventional device use and outcomes: Results from the National Cardiovascular Network Database. Am Heart J 2000;139:198-207.
3. MacIsaac AI, Ellis SG, Muller DW, Topol EJ, Whitlow PL. Comparison of three coronary stents: Clinical and angiographic outcome after elective placement in 134 consecutive patients. Cathet Cardiovasc Diagn 1994;33:199-204.
4. Kobayashi Y, De Gregorio J, Kobayashi N, Reimers B, Albiero R, Vaghetti M, Finci L, Di Mario C, Colombo A. Comparison of immediate and follow-up results of the short and long NIR stent with Palmaz-Schatz stent. Am J Cardiol 1999;84:499-504.
5. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-1688.
6. Balcon R, Beyar R, Chierchia S, De Scheerder I, Hugenholtz PG, Kiemeneij F, Meier B, Meyer J, Monassier JP, Wijns W. Recommendations on stent manufacture, implantation, and utilisation. Study Group of the Working Group on Coronary Circulation. Eur Heart J 1997;18:1536-1547.
7. Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound guided coronary stenting without anticoagulation: Frequency, predictors, and clinical outcome. J Am Coll Cardiol 1997;29:6-12.
8. De Feyter PJ, Kay P, Disco C, Serruys PW. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation 1999;100:1777-1083.
9. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-163.
10. Jenkins JS, Webel R, Laughlin MH, Rowland SM, Yoklavich MF, Branson K, Parker JL, Myers PR. The effects of intravascular stents on vasomotion in porcine coronary arteries. J Invasive Cardiol 1995;7: 200-206.
11. Carter AJ, Laird JR, Kufs WM, Bailey L, Hoopes TG, Reeves T, Farb A, Virmani R. Coronary stenting with a novel, stainless steel, balloon-expandable stent: determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model. J Am Coll Cardiol 1996;27:1270-1277.
12. Monnink SHJ, van Boven AJ, Peels HOJ, Tigchelaar I, de Kam PJ, Crijns HJ, van Oeveren W. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation. J Investig Med 1999;47:304-310.
13. Kutryk MJB, Serruys PW. Stents: The menu. In: Topol EJ, ed. Textbook of Interventional Cardiology. Philadelphia: W.B. Saunders; 1999:533-585.
14. Maderna P, Caruso D, Tremoli E, Galli G. Differential effects of oral administrations to human volunteers of acetylsalicylic acid, sodium salicylate, and indomethacin on 12-hydroxyeicosatetraenoic acid formation by stimulated platelets. Thromb Res 1988;52:197-206.
15. Hemmila I, Dakubu S, Mukkala VM, Siitari H, Lovgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 1984;137:335-343.
16. Gawaz M, Neumann FJ, Ott I, May A, Rudiger S, Schomig A. Changes in membrane glycoproteins of circulating platelets after coronary stent implantation. Heart 1996;76:166-172.
17. Jeong MH, Owen WG, Staab ME, Srivatsa SS, Sangiorgi G, Stewart M, Holmes DR, Schwartz RS. Porcine model of stent thrombosis: Platelets are the primary component of stent closure. Cathet Cardiovasc Diagn 1996;38:38-43.
18. Komatsu R, Ueda M, Naruko T, Kojima A, Becker AE. Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses. Circulation 1998;98:224-233.
19. Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998;352:673-681.
20. White CJ, Ramee SR, Collins TJ. Elective placement of the Wiktor stent after coronary angioplasty. Am J Cardiol 1994;74:274-276.
21. Bolz A, Amon M, Ozbek C, Hublein B, Schaldach M. Coating of cardiovascular stents with a semiconductor to improve their hemocompatibility. Tex Heart Inst J 1996;23:162-166.
22. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;93:2161-2169.
23. Garasic JM, Edelman ER, Squire JC, Seifert P, Williams MS, Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation 2000;101:812-818.
24. Carter AJ, Scott D, Rahdert D, Bailey L, De Vries J, Ayerdi K, Turnlund T, Jones R, Virmani R, Fischell TA. Stent design favorably influences the vascular response in normal porcine coronary arteries. J Invasive Cardiol 1999;11:127-134.
25. Schulz C, Herrmann RA. Beilharz C, Pasquantonio J, Alt E. Coronary stent symmetry and vascular injury determine experimental restenosis. Heart 2000;83:462-467.
26. Bennett CL, Connors JM, Carwile JM, Moake JL, Bell WR, Tarantolo SR, McCarthy LJ, Sarode R, Hatfield AJ, Feldman MD, Davidson CJ, Tsai HM. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000;342:1773-1777.
27. Albiero R, Hall P, Itoh A, Blengino S, Nakamura S, Martini G, Ferraro M, Colombo A. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation 1997;95:1145-1156.
28. Calver AL, Dawkins KD, Gray HH, Haywood GA, Morgan JM, Simpson IA. Intracoronary MultiLink stents: Experience in 218 patients using aspirin alone. Heart 1998;80:499-504.
29. Serruys PW, van der Giessen W, Garcia E, Macaya C, Colombo A, Rutsch W, Vrints C, Bonnier H, Mudra H, Fleck E, Ormiston J, Figulla H, Seabra-Gomes R, Veldhof S, Morel MA. Clinical and angiographic results with the Multi-Link stent implanted under intravascular ultrasound guidance (WEST-2 Study). J Invasive Cardiol 1998;10(suppl B):20B-27B.
30. Lincoff AM. Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization. Am J Cardiol 1998;82:36P-42P.
31. Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T, McFadden EP, Lablanche JM, Bertrand ME. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997;96:1454-1460.
32. Ellis SG, Guetta V, Miller D, Whitlow PL, Topol EJ. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: An analysis of results from 10,907 lesions and proposal for new classification scheme. Circulation 1999; 100:1971-1976.
33. Emanuelsson H, Serruys PW, van der Giessen W, Dawkins K, Rutsch W, Katus H, Morel MA, Veldhof S, Wijns W, Sigwart U. Clinical and angiographic results with the Multi-Link? Coronary Stent System N: The West European Stent Trial (WEST). J Invasive Cardiol 1997;9: 561-568.
34. Baim DS, Cutlip DE, Midei M, Linnemeier TJ, Schreiber TL, Cox D, Saucedo JF, Ki Ho K, Zhang Y, Robertson LK, Kuntz RE, and Kereiakes D. Acute 30-day and late clinical events in the randomized parallel-group comparison of the ACS MultiLink coronary stent system and the Palmaz-Schatz stent. Circulation 1997;96(suppl 1):593. Abstract.
35. Shah PK. Plaque disruption and coronary thrombosis: New insight into pathogenesis and prevention. Clin Cardiol 1997;20:38-44.
36. van Beusekom HM, Whelan DM, Hofma SH, Krabbendam SC, van Hinsbergh VW, Verdouw PD, van der Giessen WJ. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol 1998;32:1109-1117.
37. Schafer AI. Antiplatelet therapy. Am J Med 1996;101:199-209.